2017
Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis)
Armstrong HF, Podolanczuk AJ, Barr RG, Oelsner EC, Kawut SM, Hoffman EA, Tracy R, Kaminski N, McClelland RL, Lederer DJ. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-Dwelling Adults. MESA (Multi-Ethnic Study of Atherosclerosis). American Journal Of Respiratory And Critical Care Medicine 2017, 196: 1311-1317. PMID: 28570100, PMCID: PMC5694831, DOI: 10.1164/rccm.201701-0254oc.Peer-Reviewed Original ResearchConceptsInterstitial lung abnormalitiesMatrix metalloproteinase-7Serum MMP-7Serum MMP-7 levelsMMP-7 levelsCommunity-dwelling adultsRespiratory symptomsOutcome dataOdds of ILAMetalloproteinase-7Serum matrix metalloproteinase-7Subclinical interstitial lung diseaseCause mortality ratesIdiopathic pulmonary fibrosisInterstitial lung diseaseLog unit incrementExertional dyspneaCause mortalityLung functionPulmonary fibrosisCox regressionLung diseasePotential confoundersPrognostic biomarkerLung abnormalities
2013
A Peripheral Blood Biomarker Signature Potentially Identifies Smokers with Interstitial Lung Abnormalities
Patel A, Doyle T, Liu Y, Hatabu H, Hatabu M, Okajima Y, Risquez C, Shi Y, Osorio J, Golzarri M, Lederer J, El-Chemaly S, Pinto-Plata V, Celli B, Hunninghake G, Washko G, Sciurba F, Kaminski N, Leader J, Siegfried J, Weissfeld J, Rosas I. A Peripheral Blood Biomarker Signature Potentially Identifies Smokers with Interstitial Lung Abnormalities. CHEST Journal 2013, 144: 1029a-1029b. DOI: 10.1378/chest.1778676.Peer-Reviewed Original Research